IP Library Granted Patent US 8,707,958
Granted Patent B2
US 8,707,958 · App. 13/564,549 · Granted Apr 29, 2014

Methods and devices for deployment into a lumen

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,707,958
App. No.
13/564,549
Granted
Apr 29, 2014
Kind
B2
Abstract

The invention described is directed to an intracorporeal occluding device having elements with non-traumatic ends and devices, systems and methods for occluding the lumens of anatomical passageways and/or for delivering drugs or other substances to the bodies of human or animal subjects.

Claims (23)

1. An occluding device for a patient's body lumen, comprising:

a first expansive element secured to a central location and including a non-traumatic end radially spaced from the central location when in an expanded configuration; and

a second expansive element secured to the central location and including a non-traumatic end radially spaced from the central location when in the expanded configuration;

wherein each non-traumatic end is a separate, discrete mesh pad with fibers attached thereto, and each separate, discrete mesh pad is bonded onto a respective expansive element and configured to face an adjacent wall of the body lumen when in the expanded configuration in the body lumen.

2. The occluding device of claim 1 , further comprising an extension member secured to the central location.

3. The occluding device of claim 2 , wherein the extension members comprises a coil.

4. The occluding device of claim 1 , further comprising a membrane inter-disposed between the first and second expansive elements.

5. The occluding device of claim 4 , wherein the membrane is dissolvable in vivo.

6. The occluding device of claim 4 , wherein the membrane comprises polytetrafluoroethylene (PTFE).

7. The occluding device of claim 4 , wherein the membrane contains a contraceptive or drug.

8. The occluding device of claim 1 , further comprising fibers dispersed between the first and second expansive elements.

9. The occluding device of claim 8 , wherein the fibers dispersed between the first and second expansive elements comprise a polyester or a polyamide.

10. The occluding device of claim 8 , wherein the fibers dispersed between the first and second expansive elements comprise polyethylene terephthalate (PET) or expanded polytetrafluoroethylene (ePTFE).

11. The occluding device of claim 1 , further comprising a hydrogel element.

12. The occluding device of claim 11 , wherein the hydrogel element is porous to allow tissue ingrowth.

13. The occluding device of claim 11 , wherein the hydrogel element is secured to an extension member that is secured to the central location.

14. The occluding device of claim 11 , wherein the hydrogel element is secured to the central location.

15. The occluding device of claim 1 , wherein the fibers attached to each separate, discrete mesh pad comprise polyethylene terephthalate (PET).

16. The occluding device of claim 1 , wherein at least one of the first and second expansive elements is straight.

17. The occluding device of claim 1 , wherein at least one of the first and second expansive elements is curved.

18. The occluding device of claim 1 , wherein the first and second expansive elements are self-expansive.

19. The occluding device of claim 1 , wherein the fibers are attached to pores in each separate, discrete mesh pad.

20. The occluding device of claim 1 , wherein the fibers are attached to each separate, discrete mesh pad with a glue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2015
From: BAYER ESSURE INC.
To: BAYER HEALTHCARE LLC
Reel/Frame 036283/0050 →
CHANGE OF NAME Recorded Jan 16, 2014
From: CONCEPTUS, INC.
To: BAYER ESSURE INC.
Reel/Frame 032075/0466 →